Client News

Roquefort Therapeutics plc: Non-Executive Director Appointment
Home / Client News / Roquefort Therapeutics plc: Non-Executive Director Appointment

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, is pleased to announce the appointment of Dr Simon Sinclair as a Non-Executive Director with immediate effect.  Dr Sinclair is a commercial physician scientist leader with 20 years’ pharma, medtech and consumer healthcare industry experience in translational medicine, clinical development, medical affairs, evidence-based market access, medical safety, vigilance and real-world evidence in both executive and non-executive roles.



If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This